跳至主要内容
临床试验/NCT05182723
NCT05182723招募中不适用

Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation in Patient With Multiple Organ Dysfunction Syndrome After Heart and Aortic Surgery

Petrovsky National Research Centre of Surgery2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
2
主要终点
CRP

研究概览

简要总结

The purpose of this study is to assess the effectiveness and the safety of extracorporeal methods for removing mediators of systemic inflammation in patients with multiple organ dysfunction syndrome after heart and aorta surgery.

详细描述

After being informed about the study and potential risk, all patients with multiple organ dysfunction syndrome after heart and aorta surgery with indications for extracorporeal removal of inflammatory mediators, giving written informed consent will be included in the study.

Patients will be randomized 1:1 ratio to 1. hemoperfusion cartridge for cytokine sorption in combination with an oXiris membrane and 2. oXiris membrane.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • multiple organ dysfunction;
  • SOFA equal to or more than 4;
  • CRP equal to or more than 100 ng / ml;
  • increase of IL6 by 5 times or more

排除标准

  • the impossibility to use heparin ( bleeding; heparin-induced thrombocytopenia)

结局指标

主要结局

CRP

时间窗: 24 hours from the beginning of the study

сhange of CRP after 24 hours from baseline value

IL6

时间窗: 24 hours from the beginning of the study

сhange of IL6 after 24 hours from baseline value

SOFA

时间窗: 24 hours from the beginning of the study

change of SOFA values after 24 hours from baseline value

次要结局

  • time spent in intensive care unit(hospitalisation period, an average of 1 month)
  • inpatient stay time(through study completion, an average of 2 months)
  • extracorporeal therapy(hospitalisation period, an average of 1 month)
  • renal function of RIFLE(through study completion, an average of 2 months)
  • lethality(through study completion, an average of 2 months)

研究者

发起方
Petrovsky National Research Centre of Surgery
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aleksandr Eremenko

Clinical Professor

Petrovsky National Research Centre of Surgery

研究点 (2)

Loading locations...

相似试验